42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-1017794
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 0772a9e9-a02b-4c7d-9785-9e3fd6b67a5c
[Document ID] => 1017794
[Document naam] => Medicago CoVLP Phase 1 AS03 results for EU Dec2020.pptx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/document/VWS-WOO-08-1017794
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-1017794
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO
[DocumentPublicationDate] => 16 december 2020
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 04:31:11
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 04:31:11
)
Document: VWS-WOO-08-1017794
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201216
Geregistreerde documentnaam: Medicago CoVLP Phase 1 AS03 results for EU Dec2020.pptx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:38:21 |
| Request_Omvang openbaarmaking_documenten | 10.222 | 2025-06-22 23:38:21 |
| Request_Omvang openbaarmaking_paginas | 13.478 | 2025-06-22 23:38:21 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/file/download/inventory | 2025-06-22 23:38:21 |
| document_documentName | Medicago CoVLP Phase 1 AS03 results for EU Dec2020.pptx | 2025-06-22 23:38:21 |
| document_documentType | Presentatie | 2025-06-22 23:38:21 |
| document_documentPublicationDate | 2020-12-16 | 2025-06-22 23:38:21 |
| document_documentNumber | VWS-WOO-08-1017794 | 2025-06-22 23:38:21 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:38:21 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:38:21 |
| document_SectionAbout | 1 | 2025-06-22 23:38:21 |
| About_Datum document | 16 december 2020 | 2025-06-22 23:38:21 |
| About_Type bronbestand | Presentatie, 28 pagina's | 2025-06-22 23:38:21 |
| About_Type bronbestand_paginas | 28 | 2025-06-22 23:38:21 |
| About_Download als | PDF (11.11 MB) | 2025-06-22 23:38:21 |
| About_Documentnummer | 1017794 | 2025-06-22 23:38:21 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:38:21 |
| About_Gelakte gegevens | 5.1.1c Vertrouwelijk verstrekte bedrijfs- of fabricagegegevens Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:38:21 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:38:21 |
| About_Gelakte gegevens_linkname_1 | 5.1.1c Vertrouwelijk verstrekte bedrijfs- of fabricagegegevens | 2025-06-22 23:38:21 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Medicago CoVLP Phase 1 AS03 results for EU Dec2020.pptx (documentnummer 1ee69440-5f40-6f54-9883-bb525e933826) | 2025-06-22 23:38:21 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:38:21 |
| document_SectionRelated | 1 | 2025-06-22 23:38:21 |
| document_SectionRequest | 1 | 2025-06-22 23:38:21 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode december 2020 | 2025-06-22 23:38:21 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO | 2025-06-22 23:38:21 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode december 2020 | 2025-06-22 23:38:21 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 7 juli 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode december 2020. | 2025-06-22 23:38:21 |
| Request_Periode | December 2020 | 2025-06-22 23:38:21 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:38:21 |
| Request_Datum besluit | 7 juli 2022 | 2025-06-22 23:38:21 |
| Request_Omvang openbaarmaking | 10.222 documenten, 13.478 pagina's Inventarislijst | 2025-06-22 23:38:21 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/file/download/document/1ee69440-5f40-6f54-9883-bb525e933826 | 2025-04-20 00:14:19 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-1017794.pdf | 2025-04-20 00:14:19 |
| DocumentDownload_linkname | Download (pdf, 11.11 MB) | 2025-04-20 00:14:19 |
Archiefversies (8 rijen)
Archiefrij 1 — 2025-11-21 15:41:07
fromFile: VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.zip
documentName: VWS-WOO-08-1017794.pdf
documentType: pdf
documentCompressedSize: 7523841
documentSize: 11650643
documentCompressRatio: 64.57876187606126
documentDateModified: 2025-10-09 13:04:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:41:07
lastSeen: 2025-11-21 15:41:07
text: 1017794
Safety & Immunogenicity of a Plant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic Adjuvant in Adults Aged 18-55
EU Member States Update
Preprint link: https:/doi.org/10.1101/2020.11.04.20226282
December 2020
1017794
CONFIDENTIAL
AGENDA
Medicago and its technol...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 877db3ec090229e562493ae30a936506211870d51c75e19984ba5e957849e2c8
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: 0d94bc9e-ce75-4466-817d-40ce7c361872
textDigestSHA256: 4b412d7bc8e65b786ffd1bcfbb32cd6f7d0eab88817f047cebfff172b86b2112
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
Archiefrij 2 — 2025-11-21 15:38:42
fromFile: VWS-WOO-3395155-1032354-PDO-1f0a50fa-40da-605c-8681-b52ef042b7e3.zip
fromFilePath: archieven_files\VWS-WOO-3395155-1032354-PDO-1f0a50fa-40da-605c-8681-b52ef042b7e3.zip
documentName: VWS-WOO-08-1017794.pdf
documentType: pdf
documentCompressedSize: 7523841
documentSize: 11650643
documentCompressRatio: 64.57876187606126
documentDateModified: 2025-10-09 13:04:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:38:42
lastSeen: 2025-11-21 15:38:42
text: 1017794
Safety & Immunogenicity of a Plant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic Adjuvant in Adults Aged 18-55
EU Member States Update
Preprint link: https:/doi.org/10.1101/2020.11.04.20226282
December 2020
1017794
CONFIDENTIAL
AGENDA
Medicago and its technol...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 877db3ec090229e562493ae30a936506211870d51c75e19984ba5e957849e2c8
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 6afe1e3d-f4f5-4c36-9c70-86b2a2f950f6
textDigestSHA256: 4b412d7bc8e65b786ffd1bcfbb32cd6f7d0eab88817f047cebfff172b86b2112
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
Archiefrij 3 — 2025-09-07 17:19:54
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1017794.pdf
documentName: VWS-WOO-08-1017794.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 11650643
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:19:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:19:54
lastSeen: 2025-09-07 17:19:54
text: 1017794
Safety &Immunogenicity ofaPlant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic AdjuvantinAdults Aged 18-55
EUMember States Update
Preprint link:https:/doi.org/10.1101/2020.11.04.20226282 December 20201017794
CONFIDENTIAL
AGENDA
Medicago and itstechnologies
CoVLP prec...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 877db3ec090229e562493ae30a936506211870d51c75e19984ba5e957849e2c8
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_15509_bca3445f5cdec124f6580903a85a96c9
textDigestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
Archiefrij 4 — 2025-09-04 16:57:59
fromFile: VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.1.zip
documentName: VWS-WOO-08-1017794.pdf
documentType: pdf
documentCompressedSize: 7523841
documentSize: 11650643
documentCompressRatio: 64.57876187606126
documentDateModified: 2025-05-01 20:26:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:57:59
lastSeen: 2025-11-21 13:47:41
text: 1017794
Safety &Immunogenicity ofaPlant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic AdjuvantinAdults Aged 18-55
EUMember States Update
Preprint link:https:/doi.org/10.1101/2020.11.04.20226282 December 20201017794
CONFIDENTIAL
AGENDA
Medicago and itstechnologies
CoVLP prec...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 877db3ec090229e562493ae30a936506211870d51c75e19984ba5e957849e2c8
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.zip_2744
textDigestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
Archiefrij 5 — 2025-03-18 09:30:24
fromFile: 2024.075-VWS-WOO-3395155-1032354-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3395155-1032354-PDO.zip
documentName: VWS-WOO-08-1017794.pdf
documentType: pdf
documentCompressedSize: 7512710
documentSize: 11650643
documentCompressRatio: 64.48322208482399
documentDateModified: 2024-12-17 13:52:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:24
lastSeen: 2025-03-18 09:30:24
text: 1017794
Safety &Immunogenicity ofaPlant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic AdjuvantinAdults Aged 18-55
EUMember States Update
Preprint link:https:/doi.org/10.1101/2020.11.04.20226282 December 20201017794
CONFIDENTIAL
AGENDA
Medicago and itstechnologies
CoVLP prec...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 319918
textDigestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
Archiefrij 6 — 2025-02-27 09:25:04
fromFile: 2023.057-VWS-WOO-3395155-1032354-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3395155-1032354-PDO.zip
documentName: VWS-WOO-08-1017794.pdf
documentType: pdf
documentCompressedSize: 7512710
documentSize: 11650643
documentCompressRatio: 64.48322208482399
documentDateModified: 2024-12-17 13:52:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:04
lastSeen: 2025-02-27 09:25:04
text: 1017794
Safety &Immunogenicity ofaPlant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic AdjuvantinAdults Aged 18-55
EUMember States Update
Preprint link:https:/doi.org/10.1101/2020.11.04.20226282 December 20201017794
CONFIDENTIAL
AGENDA
Medicago and itstechnologies
CoVLP prec...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 232472
textDigestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
Archiefrij 7 — 2025-02-18 12:18:13
fromFile: VWS-WOO-3395155-1032354-PDO-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3395155-1032354-PDO-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
documentName: VWS-WOO-08-1017794.pdf
documentType: pdf
documentCompressedSize: 7512710
documentSize: 11650643
documentCompressRatio: 64.48322208482399
documentDateModified: 2024-12-17 13:52:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1017794
Safety &Immunogenicity ofaPlant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic AdjuvantinAdults Aged 18-55
EUMember States Update
Preprint link:https:/doi.org/10.1101/2020.11.04.20226282 December 20201017794
CONFIDENTIAL
AGENDA
Medicago and itstechnologies
CoVLP prec...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 105504
textDigestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
Archiefrij 8 — 2025-02-18 12:18:07
fromFile: Besluit__dossier_nr_-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
documentName: VWS-WOO-08-1017794-Medicago_CoVLP_Phase_1_AS03_results_for_EU_Dec2020.pptx.pdf
documentType: pdf
documentCompressedSize: 7512710
documentSize: 11650643
documentCompressRatio: 64.48322208482399
documentDateModified: 2024-08-28 15:25:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:07
lastSeen: 2025-02-18 12:18:07
text: 1017794
Safety &Immunogenicity ofaPlant-Derived Coronavirus-Like Particle
Vaccine Candidate with GSK’s Pandemic AdjuvantinAdults Aged 18-55
EUMember States Update
Preprint link:https:/doi.org/10.1101/2020.11.04.20226282 December 20201017794
CONFIDENTIAL
AGENDA
Medicago and itstechnologies
CoVLP prec...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 80482
textDigestSHA256: 4db3d04d51199923bba750471243a603175549b76de1055346de08c8e098d79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1017794
(dit is ook een speeltuin)